01
Two forms under one name
The published human pharmacology of CJC-1295 concerns the form carrying a drug affinity complex: a maleimido group at the C-terminus that binds covalently to plasma proteins such as serum albumin, producing conjugates with a much longer half-life than the unconjugated peptide. Anti-doping work treats the two as separate analytes and identifies their metabolites separately. The form sold here is the one without that complex, and the multi-day duration reported below belongs to the other.
Leave a researcher note